PEAR1 and respiratory system disorder: Here we show that the intratracheal nebulization of monoclonal antibodies targeting PEAR1 significantly ameliorates the degree of PF, indicating that the inhalation of antibodies may serve as an efficient strategy for the treatment of respiratory diseases.